0 Comentários
0 Compartilhamentos
87 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
BRCA1 and BRCA2 Genes Market Expands as Genetic Testing Adoption Increases in Oncology Care"Comprehensive Outlook on Executive Summary Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market Size and Share CAGR Value Data Bridge Market Research analyses that the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market, which is USD 5.62 billion in 2022, is expected to reach USD 11.28 billion by 2030, at a CAGR of 9.10% during the forecast period 2023 to...0 Comentários 0 Compartilhamentos 171 Visualizações 0 Anterior
-
Cell Cycle Inhibitors Market Driving Oncology Innovation and Targeted Drug DeliveryExecutive Summary Cell Cycle Inhibitors Market : CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. The market insights gained through this Cell Cycle Inhibitors Market research analysis report facilitates more defined...0 Comentários 0 Compartilhamentos 994 Visualizações 0 Anterior
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Expands with Precision Oncology Investments"Latest Insights on Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Share and Size CAGR Value The Europe non-small cell lung cancer diagnostics market size was valued at USD 850.07 billion in 2025 and is expected to reach USD 2181.09 billion by 2033, at a CAGR of 12.50% during the forecast period The study and analysis...0 Comentários 0 Compartilhamentos 57 Visualizações 0 Anterior
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Poised for Growth Amid Advances in Precision Oncology"Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Size and Share Forecast CAGR Value Europe non-small cell lung cancer diagnostics market is expected to reach USD 846.60 million by 2028 from USD 331.31 million in 2020, growing at a steady CAGR of 12.5% in the forecast period of 2021 to 2028. By considering a definite base year and historic year, calculations...0 Comentários 0 Compartilhamentos 191 Visualizações 0 Anterior
-
Glioblastoma Multiforme Treatment Market Advances with Breakthrough Therapies and Precision Oncology Developments"Executive Summary Glioblastoma Multiforme Treatment Market Size and Share: Global Industry Snapshot CAGR Value Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. For the growth of any business, Glioblastoma Multiforme...0 Comentários 0 Compartilhamentos 41 Visualizações 0 Anterior
-
Global Oncology Information System Market to Reach $4.65 Billion by 2033Market Overview The global oncology information system market size was valued at USD 2.43 billion in 2024 and it is projected to reach from USD 2.61 billion in 2025 to USD 4.65 billion by 2033, growing at a CAGR of 7.5% during the forecast period (2025-2033). The global Oncology Information System market continues to evolve rapidly, driven by...0 Comentários 0 Compartilhamentos 554 Visualizações 0 Anterior
-
Hemato Oncology Testing Market Size, Precision Medicine Trends, and Strategic Industry Outlook 2032"Latest Insights on Executive Summary Hemato Oncology Testing Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers This Hemato Oncology Testing Market research report proves to be true in serving the purpose of businesses of making enhanced...0 Comentários 0 Compartilhamentos 357 Visualizações 0 Anterior
-
Hemato Oncology Testing Market Size, Share, Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers Hemato Oncology Testing Market report offers the most appropriate solution for the business requirements in many ways. To be...0 Comentários 0 Compartilhamentos 350 Visualizações 0 Anterior
-
High-Potency Oncology API (HPAPI) Market Analysis, Size, Share, Segments & ForecastExecutive Summary High-Potency Oncology API (HPAPI) Market: Share, Size & Strategic Insights The global High-Potency Oncology API (HPAPI) market size was valued at USD 693 Million in 2025 and is expected to reach USD 1421.90 Million by 2033, at a CAGR of 9.40% during the forecast period. The key topics that have been described in this High-Potency...0 Comentários 0 Compartilhamentos 48 Visualizações 0 Anterior
-
Ipilimumab Market Size, Share, and Immuno-Oncology Growth Trends: Strategic Industry Forecast 2032"Executive Summary Ipilimumab Market: Growth Trends and Share Breakdown Data Bridge Market Research analyses that the ipilimumab? market was valued at USD 2.026 million in 2021 and is expected to reach USD 4.34 million by 2029, registering a CAGR of 10.0% during the forecast period of 2022 to 2029 The Ipilimumab Market report has been formed with the appropriate expertises that utilize...0 Comentários 0 Compartilhamentos 182 Visualizações 0 Anterior
-
Is the Epigenetics-Based Therapeutics Market Transforming Precision Medicine and Oncology?"Executive Summary Epigenetics-Based Therapeutics Market Research: Share and Size Intelligence CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The all-inclusive Epigenetics-Based Therapeutics...0 Comentários 0 Compartilhamentos 37 Visualizações 0 Anterior
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Comentários 0 Compartilhamentos 627 Visualizações 0 Anterior
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Comentários 0 Compartilhamentos 504 Visualizações 0 Anterior
-
How are new therapies reshaping the urothelial cancer drugs market?Competitive Analysis of Executive Summary Urothelial Cancer Drugs Market Size and Share CAGR Value The global Urothelial Cancer Drugs market size was valued at USD 1.44 billion in 2024 and is expected to reach USD 2.80 billion by 2032, at a CAGR of 8.7% during the forecast period Keeping into consideration the customer requirement, an influential Urothelial Cancer Drugs...0 Comentários 0 Compartilhamentos 387 Visualizações 0 Anterior
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
mTOR Inhibitor Oncology Drug Market Strengthens with Rising Cancer Research Investments"Detailed Analysis of Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period With this mTOR Inhibitor Oncology Drug Market report,...0 Comentários 0 Compartilhamentos 48 Visualizações 0 Anterior
-
Oncology Biosimilars Market Share, CAGR, and Pharmaceutical Innovation Trends: Strategic Growth Analysis 2032"Executive Summary Oncology Biosimilars Market Size and Share: Global Industry Snapshot Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. For the growth of any business, Oncology Biosimilars Marketresearch report plays a very important...0 Comentários 0 Compartilhamentos 226 Visualizações 0 Anterior
-
Oncology Biosimilars Segment Analysis: Market Share, Opportunities, and Future Outlook Forecast to 2030"Executive Summary Oncology Biosimilars Market Size, Share, and Competitive Landscape Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. An exceptional Oncology Biosimilars Market research document can be formulated well with the...0 Comentários 0 Compartilhamentos 270 Visualizações 0 Anterior
-
Radiation Oncology Treatment Planning Software Market Advances with AI Precision Tools"Global Executive Summary Radiation Oncology Treatment Planning Software Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period 2023 to 2030. To gain...0 Comentários 0 Compartilhamentos 916 Visualizações 0 Anterior
Páginas impulsionada
English
Kiswahili
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek
